Company intelligence / Profile preview

Translumina

Hechingen, Baden-Württemberg, Germanytranslumina.com ↗

Ownership: Private
Development stage: Other

Overview

Translumina’s drug-eluting stents have demonstrated over ten years of safety and efficacy data in clinical studies. Their products are recommended by leading cardiological societies and used globally for coronary interventions. The company emphasizes innovation, quality manufacturing, and international regulatory compliance.

Therapeutic areas: Cardiovascular
Modalities: DeviceDrug-eluting stentsDrug-coated balloonsCathetersVascular accessories
Industry: Therapeutic Medical Devices

Partnerships

German Heart Centre Munichstrategic partnerships with hospitals, engineering institutes, tech companies, renowned cardiologists

Beyond the preview

Go deeper on Translumina.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Translumina.

Explore the full profile